Deep Track Capital, LP - 30 Sep 2025 SCHEDULE 13G/A Report for INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value (INO)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value
Symbol
INO
Shares outstanding
54,555,851 shares
Disclosed Ownership
1,314,796 shares
Ownership
2.4%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 08:15:56 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 2.4% 1,314,796 0 1,314,796 David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 2.4% 1,314,796 0 1,314,796 David Kroin David Kroin, Director
David Kroin 2.4% 1,314,796 0 1,314,796 David Kroin David Kroin